Arca
Skip to content
Tools
Tools

Epidermal growth factor receptor

Family in Homo sapiens that 4 drugs act on.

  • Drugs that act on it: 4
  • Approved: 1
  • In phases 1 to 3: 3
  • Sponsors: 4
  • Genes: 4

Who is on it, and how far along

Every drug ChEMBL records acting on EGFR, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 3
  • Other 1

Approved1

  • Vandetanib

Phase 31

  • Poziotinib

Phase 21

  • Tarloxotinib

Phase 11

  • KBP5209

Sponsors

Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

  • Sihuan Pharmaceutical Holdings Group Ltd.125%

The landscape

Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Epidermal growth factor receptor inhibitor.
VandetanibBoxed warningApprovedSanofiSmall moleculeInhibitor3
PoziotinibPhase 3Spectrum PharmaceuticalsSmall moleculeInhibitor0
TarloxotinibPhase 2Rain OncologySmall moleculeInhibitor0
KBP5209Phase 1Sihuan Pharmaceutical Holdings Group Ltd.OtherInhibitor0

Open trials

The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 3 in all, from ClinicalTrials.gov.
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid CancerVandetanibPhase 2RecruitingWest China HospitalJul 1, 2024
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid CancerVandetanibPhase 3Active, not recruitingLoxo Oncology, Inc.Dec 26, 2019
SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast CancerVandetanibPhase 2Active, not recruitingUNICANCERNov 24, 2014

Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2363049, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.